BROADCASTS.com

b'

Dr. Josh Denny, M.D., M.S., is the Chief Executive Officer (CEO) of the National Institutes of Health\\u2019s All of Us Research Program ( https://allofus.nih.gov/about/who-we-are/joshua-denny ), an initiative that seeks to enroll at least one million diverse participants to build an indispensable resource that accelerates precision medicine for all populations. Dr. Denny has been involved since the program\\u2019s inception when he was a member of the NIH Precision Medicine Initiative Working Group of the Advisory Committee to the Director ( https://allofus.nih.gov/about/who-we-are/pmi-working-group-advisory-committee-director ), which developed the program\\u2019s initial scientific blueprint and he then led the program\\u2019s initial prototyping project and the All of Us Data and Research Center. He was named CEO of All of Us in January 2020. Before joining NIH, Dr. Denny was a practicing physician and held several leadership positions at Vanderbilt University Medical Center, including professor of biomedical informatics and medicine, founding director of the Center for Precision Medicine, and vice president for personalized medicine. At Vanderbilt, he led discovery and implementation projects in precision medicine, including clinical pharmacogenomics and Vanderbilt\\u2019s DNA biobank. He was a pioneer in the use of electronic health records for genomics studies, including the initial descriptions of phenome\\u2010wide association studies and phenotype risk scores. Dr. Denny is an elected member of the National Academy of Medicine, the American Society for Clinical Investigation, and the American College of Medical Informatics. Dr. Denny has a Medical Degree, and a Master\\u2019s Degree in Biomedical Informatics, from Vanderbilt University School of Medicine.\\xa0